|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8,753.00 JPY | +4.20% |
|
+6.07% | +6.19% |
| Capitalization | 13,824B 87.31B 74.31B 69.02B 64.71B 120B 7,997B 128B 788B 312B 3,778B 327B 321B | P/E ratio 2025 * |
32.3x | P/E ratio 2026 * | 28.6x |
|---|---|---|---|---|---|
| Enterprise value | 12,954B 81.82B 69.64B 64.67B 60.64B 113B 7,494B 120B 738B 293B 3,540B 307B 301B | EV / Sales 2025 * |
10.4x | EV / Sales 2026 * | 9.54x |
| Free-Float |
38.09% | Yield 2025 * |
3.02% | Yield 2026 * | 1.53% |
Last Transcript: Chugai Pharmaceutical Co., Ltd.
| 1 day | +4.20% | ||
| 1 week | +6.07% | ||
| Current month | +6.19% | ||
| 1 month | +4.95% | ||
| 3 months | +22.35% | ||
| 6 months | +22.99% | ||
| Current year | +6.19% |
| 1 week | 8,168 |  | 8,796 |
| 1 month | 8,168 | | 8,796 |
| Current year | 8,168 | | 8,796 |
| 1 year | 5,942 | | 8,796 |
| 3 years | 3,203 | | 8,796 |
| 5 years | 3,191 | | 8,796 |
| 10 years | 1,003.33 | | 8,796 |
| Manager | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 62 | 01/01/2021 |
Iwaaki Taniguchi
DFI | Director of Finance/CFO | - | 28/03/2024 |
Junichi Nezu
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Motoo Ueno
BRD | Director/Board Member | 68 | 01/03/1993 |
Masayuki Oku
BRD | Director/Board Member | 81 | 01/03/2015 |
| Director/Board Member | 77 | 01/03/2017 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +3.74% | 6.57% | 29 M€ | |
| +6.32% | 1.87% | 69 M€ | |
| +4.11% | 1.59% | 4 M€ | |
| +6.96% | 1.53% | 73,790 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.20% | +6.07% | +33.31% | +158.05% | 87.31B | |
| +0.82% | +5.27% | +44.22% | +214.21% | 974B | |
| +0.22% | -0.49% | +50.40% | +29.48% | 526B | |
| +0.91% | +0.63% | +28.91% | +45.81% | 385B | |
| -0.19% | -0.49% | +26.53% | +17.52% | 376B | |
| +0.49% | -3.27% | +23.05% | +23.14% | 284B | |
| +0.45% | -0.07% | +27.99% | +35.22% | 279B | |
| -1.74% | -1.61% | +14.11% | -0.69% | 271B | |
| +1.83% | +3.90% | -30.46% | -16.30% | 277B | |
| +1.01% | +5.16% | +26.93% | +31.85% | 187B | |
| Average | +0.77% | +1.32% | +24.50% | +53.83% | 364.69B | |
| Weighted average by Cap. | +0.52% | +2.00% | +29.72% | +76.71% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1,248B 7.88B 6.71B 6.23B 5.84B 10.88B 722B 11.53B 71.13B 28.19B 341B 29.56B 28.95B | 1,334B 8.43B 7.17B 6.66B 6.24B 11.63B 772B 12.33B 76.04B 30.13B 365B 31.59B 30.95B |
| Net income | 429B 2.71B 2.3B 2.14B 2.01B 3.74B 248B 3.96B 24.43B 9.68B 117B 10.15B 9.94B | 483B 3.05B 2.6B 2.41B 2.26B 4.21B 280B 4.47B 27.55B 10.92B 132B 11.45B 11.21B |
| Net Debt | -870B -5.49B -4.68B -4.34B -4.07B -7.58B -503B -8.04B -49.59B -19.65B -238B -20.6B -20.18B | -1,094B -6.91B -5.88B -5.46B -5.12B -9.54B -633B -10.11B -62.37B -24.71B -299B -25.91B -25.38B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/01/26 | 8,753.00 ¥ | +4.20% | 3,173,700 |
| 22/01/26 | 8,400.00 ¥ | +1.02% | 1,990,700 |
| 21/01/26 | 8,315.00 ¥ | +0.87% | 1,755,300 |
| 20/01/26 | 8,243.00 ¥ | +0.18% | 1,557,500 |
| 19/01/26 | 8,228.00 ¥ | -0.29% | 1,506,200 |
Delayed Quote Japan Exchange, January 23, 2026 at 10:30 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4519 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition